Table 6.
Prevalence of components by MetS definition in participants identified as having MetSa
| Component | WHO (1998) (n=1007) | 95% CI | NCEP-ATP III (2004) (n=1896) | 95% CI | IDF (2005) (n=2360) | 95% CI | JIS (2009) (n=2448) | 95% CI |
|---|---|---|---|---|---|---|---|---|
| Obesity | 99.3% | 98.6-99.7 | 86.6% | 85.0-88.1 | 100.0%* | 99.8-100.0 | 96.4% | 95.6-97.1 |
| Lipid metabolismb | 51.6% | 48.5-54.7 | ||||||
| Triglycerides | 56.1% | 53.9-58.3 | 46.1% | 44.1-48.1 | 47.3% | 45.3-49.3 | ||
| HDL-C | 40.1% | 37.9-42.3 | 33.5% | 31.6-35.4 | 33.8% | 32.0-35.7 | ||
| Blood pressure | 90.6% | 88.6-92.3 | 85.9% | 84.3-87.4 | 91.4% | 90.2-92.5 | 91.6% | 90.4-92.6 |
| Glucose/diabetes | 100.0%* | 99.6-100.0 | 84.7% | 83.0-86.3 | 83.9% | 82.4-85.3 | 84.2% | 82.7-85.6 |
* Required component
aPrevalences were calculated in participants classified as having MetS, separately for each definition
bLipid metabolism included both triglycerides and HDL-C in the WHO definition